跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BIBAG - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
BIBAG
Authorized
STANDARD
BIBAG
fresenius medical care canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
7a3b9fa01b3ca122
Company
fresenius medical care canada inc
Type
Standard
Approval Details
Approval Id
7a3b9fa01b3ca122
Drug Approval Canada Name
BIBAG
Product Name
BIBAG
Status
Marketed
Status Date
2022-04-26
Original Market Date
2020-01-30
Din
02487756
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Haemodialysis
Schedule
Ethical
Ahfs
40:34.00*
Atc Original
B05ZA HEMODIALYTICS, CONCENTRATES
Atc Name
b 05 za
Aig Number
0104153026
Company Name
fresenius medical care canada inc
Company Address
45 Staples Ave, Suite 110, Richmond Hill, Ontario, Canada, L4B 4W6
Active Ingredients
SODIUM BICARBONATE
900 G / BAG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
7a3b9fa01b3ca122
Type
Standard
Back to Health Canada Approvals